Lassen Therapeutics
PrivateLast Round
Series B
Dec 19, 2023
Total Funding Raised
$116M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Lassen Therapeutics operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Series B round in December 2023.
Lassen Therapeutics is a biopharmaceutical company that develops antibody-based therapeutics for the treatment of fibrotic, inflammatory, and oncology-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lassen Therapeutics Comparables
Compare Lassen Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novartis | 79% | |
| Alphabet Inc. | 74% | |
| Amgen | 74% |
For institutional investors. Book with your work email.
Lassen Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 19, 2023 | ||||
| Series A | Jun 17, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Lassen Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longitude Capital | Series B |
| Frazier Healthcare Partners | Series A |
| DC Investment Partners | Series A |
| Catalio Capital Management | Series B |
| Frazier Life Sciences | Series B |
| BVF Partners L.P. | Series B |
| Alta Administration | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors increased 118% MoM.
- Jun 17, 2020
$31M round led by Frazier Healthcare Partners
For institutional investors. Book with your work email.
Lassen Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lassen Therapeutics's valuation, stock price, and market status.
Is Lassen Therapeutics a public or private company?
Lassen Therapeutics is a private company.
What is the current stock price of Lassen Therapeutics?
Lassen Therapeutics is a private company, so its shares have no public market price. Caplight tracks Lassen Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lassen Therapeutics worth (valuation)?
Valuation information for Lassen Therapeutics is not publicly available.
Can I buy Lassen Therapeutics stock?
Lassen Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lassen Therapeutics's last funding round?
Lassen Therapeutics's most recent funding round was Series B on December 19, 2023.
Who are the main investors in Lassen Therapeutics?
Key investors in Lassen Therapeutics include Longitude Capital, Frazier Healthcare Partners, Frazier Life Sciences.
Will Lassen Therapeutics IPO soon?
No public IPO plans have been announced for Lassen Therapeutics.
How can I track Lassen Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Lassen Therapeutics's shares on secondary markets.